Dauerman HL - Search Results

1

Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.

Gogo PB Jr, Schneider DJ, Terrien EF, Watkins MW, Sobel BE, Dauerman HL. Gogo PB Jr, et al. Among authors: dauerman hl. Am J Cardiol. 2005 Aug 15;96(4):538-42. doi: 10.1016/j.amjcard.2005.04.016. Am J Cardiol. 2005. PMID: 16098308

2

Current treatment options for patients undergoing rescue coronary intervention.

Guigauri P, Dauerman HL. Guigauri P, et al. Among authors: dauerman hl. Minerva Cardioangiol. 2002 Apr;50(2):85-93. Minerva Cardioangiol. 2002. PMID: 12032462 Review.

3

Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.

Dauerman HL, Goldberg RJ, White K, Gore JM, Sadiq I, Gurfinkel E, Budaj A, Lopez de Sa E, Lopez-Sendon J; Global Registry of Acute Coronary Events. GRACE Investigators. Dauerman HL, et al. Am J Cardiol. 2002 Oct 15;90(8):838-42. doi: 10.1016/s0002-9149(02)02704-2. Am J Cardiol. 2002. PMID: 12372570

4

Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting.

Aggarwal A, Schneider DJ, Terrien EF, Terrien CM Jr, Sobel BE, Dauerman HL. Aggarwal A, et al. Among authors: dauerman hl. Am J Cardiol. 2003 Jun 1;91(11):1346-9. doi: 10.1016/s0002-9149(03)00327-8. Am J Cardiol. 2003. PMID: 12767431 Clinical Trial. No abstract available.

5

Outcomes of percutaneous coronary intervention among elderly patients in cardiogenic shock: a multicenter, decade-long experience.

Dauerman HL, Ryan TJ Jr, Piper WD, Kellett MA, Shubrooks SJ, Robb JF, Hearne MJ, Watkins MW, Hettleman BD, Silver MT, Niles NW, Malenka DJ. Dauerman HL, et al. J Invasive Cardiol. 2003 Jul;15(7):380-4. J Invasive Cardiol. 2003. PMID: 12840234

6

Synergistic treatment of ST-segment elevation myocardial infarction with pharmacoinvasive recanalization.

Dauerman HL, Sobel BE. Dauerman HL, et al. J Am Coll Cardiol. 2003 Aug 20;42(4):646-51. doi: 10.1016/s0735-1097(03)00762-9. J Am Coll Cardiol. 2003. PMID: 12932595 Free article.

7

Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting.

Aggarwal A, Schneider DJ, Sobel BE, Dauerman HL. Aggarwal A, et al. Among authors: dauerman hl. Am J Cardiol. 2003 Oct 15;92(8):924-9. doi: 10.1016/s0002-9149(03)00971-8. Am J Cardiol. 2003. PMID: 14556867

8

Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response.

Aggarwal A, Schneider DJ, Terrien EF, Gilbert KE, Dauerman HL. Aggarwal A, et al. Among authors: dauerman hl. J Thromb Thrombolysis. 2003 Feb;15(1):25-31. doi: 10.1023/a:1026188200939. J Thromb Thrombolysis. 2003. PMID: 14574073 Clinical Trial.

9

Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques.

Aggarwal A, Schneider DJ, Terrien EF, Sobel BE, Dauerman HL. Aggarwal A, et al. Among authors: dauerman hl. Am J Cardiol. 2004 Jan 1;93(1):6-9. doi: 10.1016/j.amjcard.2003.09.003. Am J Cardiol. 2004. PMID: 14697457

10

Endothelial dysfunction and inflammation after percutaneous coronary intervention.

Blum A, Schneider DJ, Sobel BE, Dauerman HL. Blum A, et al. Among authors: dauerman hl. Am J Cardiol. 2004 Dec 1;94(11):1420-3. doi: 10.1016/j.amjcard.2004.07.146. Am J Cardiol. 2004. PMID: 15566916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters